Fresenius Medical Care Co AG & Co KGaA, known by the ticker symbol FMS is a large-cap healthcare facilities organization, operating in the healthcare business sector. This is my first report on FMS for any of my seven dog of the week portfolios. 

Fresenius Medical Care is the largest dialysis company in the world, treating about 345,000 patients from over 4,100 clinics across the globe as of September 2021. 

In addition to providing dialysis services, the firm is a leading supplier of dialysis products, including machines, dialyzers, and concentrates. Fresenius accounts for about 35% of the global dialysis products market and benefits from being the world's only fully integrated dialysis business. 

Services account for roughly 80% of firm-wide revenue, including care coordination and ancillary operations, while products account for the other roughly 20%. Products typically enjoy a higher margin, making them a strong contributor to the bottom line.

The company sells its products to dialysis clinics, hospitals, and specialized treatment clinics directly, as well as through local sales forces, independent distributors, dealers, and sales agents.

Photo by Matheus Ferrero on Unsplash

As of December 31, 2020, it operated 4,092 outpatient dialysis clinics in approximately 150 countries. 

Fresenius Medical Care AG & Co. KGaA was incorporated in 1996 and is headquartered in Bad Homburg, Germany.

Three key data points gauge any dividend equity or fund such as Fresenius Medical Care Co AG & Co KGaA, (FMS):

(1) Price

(2) Dividends

(3) Returns

Those three basic keys best tell whether any company has made, is making, and will make money. 

FMS Price

Fresenius's price per share was $34.41 as of yesterday. One year ago its price was $35.37. Therefore PRGO's share price fell $0.96 or over 2.7% in the past year.

If FMS's stock trades in the range of $30.00 to $40.00 this next year, its recent $34.41 share price might rise by $3.09 to reach $37.50 by February 10, 2023. This estimate is $0.35 under the median of one year target single share prices from 6 analysts tracking the stock for their brokerage houses.

FMS Dividends

Fresenius's most recent annual dividend of $0.82 was paid to shareholders on June 7th, to those on record as of May 24th. The FMS Annual dividend payout per share of $0.82 yields 2.38% per yesterday's $34.41. closing price. 

FMS has paid annual dividend payouts increasing annually since June 1999. That stretch will mark 23 years in June.

PRGO Returns

Adding the $0.82 annual FMS forward-looking dividend to its estimated one-year price upside of $3.09 shows a $3.91 potential gross gain, per share, to be reduced by any costs to trade FMS shares.  

At yesterday's $34.41 price per share, a little under $1000 would buy 29 shares.

A $10 broker fee (if charged) would be paid half at purchase and half at sale and might cost us about $0.34 per share.

Subtract that maybe $0.34 brokerage cost from my estimated $3.91 gross gain estimate per share results in a net gain of $3.57 X 29 shares = $103.53 for a 10.35% net gain on a $997.89 investment.

So it is that Fresenius Medical Care Co AG & Co KGaA (FMS) shows a possible 10.35% net gain including a 2.38% forward estimated dividend yield. 

Over the next year at this time, our $1000 investment in Fresenius Medical Care Co AG & Co KGaA (FMS) could generate $23.80 in cash dividends alone. Note that a single share of FMS stock bought at yesterday's share price of $34.41 is over $10 more than the dividend income from $1000.00 invested. So, by my dogcatcher ideal, now is not the time to pickup Fresenius Medical Care Co AG & Co KGaA (FMS) shares. The estimated next-year dividend from $1K invested is $10.61 less than FMS's single share price. Consider yourself alerted. Its a sign! Wait for FMS shares to pull back to $28.60.

All of the estimates above are speculation based on the past history of Fresenius Medical Care Co AG & Co KGaA (FMS). Only time and money invested in this stock will determine its market value.